CN107778331A - 一种甲啶铂的提纯方法 - Google Patents
一种甲啶铂的提纯方法 Download PDFInfo
- Publication number
- CN107778331A CN107778331A CN201610741480.6A CN201610741480A CN107778331A CN 107778331 A CN107778331 A CN 107778331A CN 201610741480 A CN201610741480 A CN 201610741480A CN 107778331 A CN107778331 A CN 107778331A
- Authority
- CN
- China
- Prior art keywords
- picoplatin
- solvent
- organic solvent
- crude product
- purification
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- IIMIOEBMYPRQGU-UHFFFAOYSA-L picoplatin Chemical compound N.[Cl-].[Cl-].[Pt+2].CC1=CC=CC=N1 IIMIOEBMYPRQGU-UHFFFAOYSA-L 0.000 title claims abstract description 31
- 229950005566 picoplatin Drugs 0.000 title claims abstract description 30
- 238000000034 method Methods 0.000 title claims abstract description 21
- 238000000746 purification Methods 0.000 title claims abstract description 11
- 239000012043 crude product Substances 0.000 claims abstract description 18
- 239000002904 solvent Substances 0.000 claims abstract description 13
- 239000003960 organic solvent Substances 0.000 claims abstract description 12
- 238000002425 crystallisation Methods 0.000 claims abstract description 6
- 230000008025 crystallization Effects 0.000 claims abstract description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 29
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 8
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 4
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 4
- 239000008213 purified water Substances 0.000 claims description 4
- 238000001953 recrystallisation Methods 0.000 claims description 3
- 125000001033 ether group Chemical group 0.000 claims description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical group CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims 2
- 239000012535 impurity Substances 0.000 abstract description 13
- 230000000118 anti-neoplastic effect Effects 0.000 abstract description 3
- 238000003756 stirring Methods 0.000 description 24
- 238000004128 high performance liquid chromatography Methods 0.000 description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- 238000001514 detection method Methods 0.000 description 9
- 239000007787 solid Substances 0.000 description 9
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 8
- 235000019441 ethanol Nutrition 0.000 description 4
- 229910052697 platinum Inorganic materials 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 3
- 239000003643 water by type Substances 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 239000012065 filter cake Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000008236 heating water Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 150000003057 platinum Chemical class 0.000 description 1
- RJISOXBAUVEBHP-UHFFFAOYSA-N platinum;pyridine Chemical compound [Pt].C1=CC=NC=C1 RJISOXBAUVEBHP-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 230000003335 steric effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0086—Platinum compounds
- C07F15/0093—Platinum compounds without a metal-carbon linkage
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyridine Compounds (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610741480.6A CN107778331B (zh) | 2016-08-27 | 2016-08-27 | 一种甲啶铂的提纯方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610741480.6A CN107778331B (zh) | 2016-08-27 | 2016-08-27 | 一种甲啶铂的提纯方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107778331A true CN107778331A (zh) | 2018-03-09 |
CN107778331B CN107778331B (zh) | 2020-06-30 |
Family
ID=61440749
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610741480.6A Active CN107778331B (zh) | 2016-08-27 | 2016-08-27 | 一种甲啶铂的提纯方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107778331B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110305033A (zh) * | 2018-03-20 | 2019-10-08 | 鲁南制药集团股份有限公司 | 一种西司他汀钠中间体的纯化方法 |
CN113173953A (zh) * | 2021-04-12 | 2021-07-27 | 昆明贵研药业有限公司 | 用于制备抗肿瘤药物的高纯洛铂三水合物的提纯方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101302235A (zh) * | 2008-06-30 | 2008-11-12 | 昆明贵研药业有限公司 | 甲啶铂的提纯 |
US20120123121A1 (en) * | 2009-06-12 | 2012-05-17 | Poniard Pharmaceuticals, Inc. | Synthesis of picoplatin |
CN104288119A (zh) * | 2007-02-09 | 2015-01-21 | 英卡塔有限公司 | 稳定化的吡铂口服剂型 |
-
2016
- 2016-08-27 CN CN201610741480.6A patent/CN107778331B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104288119A (zh) * | 2007-02-09 | 2015-01-21 | 英卡塔有限公司 | 稳定化的吡铂口服剂型 |
CN101302235A (zh) * | 2008-06-30 | 2008-11-12 | 昆明贵研药业有限公司 | 甲啶铂的提纯 |
US20120123121A1 (en) * | 2009-06-12 | 2012-05-17 | Poniard Pharmaceuticals, Inc. | Synthesis of picoplatin |
Non-Patent Citations (1)
Title |
---|
普绍平等,: "甲啶铂的合成_表征_理化性质与晶体结构", 《CHINESE JOURNAL OF NEW DRUGS》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110305033A (zh) * | 2018-03-20 | 2019-10-08 | 鲁南制药集团股份有限公司 | 一种西司他汀钠中间体的纯化方法 |
CN113173953A (zh) * | 2021-04-12 | 2021-07-27 | 昆明贵研药业有限公司 | 用于制备抗肿瘤药物的高纯洛铂三水合物的提纯方法 |
CN113173953B (zh) * | 2021-04-12 | 2022-06-10 | 昆明贵研药业有限公司 | 用于制备抗肿瘤药物的高纯洛铂三水合物的提纯方法 |
Also Published As
Publication number | Publication date |
---|---|
CN107778331B (zh) | 2020-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105968093B (zh) | 琥珀酸曲格列汀的制备方法 | |
FI82189B (fi) | Foerfarande foer framstaellning av en stabil modifikation av torasemid. | |
CN106831772B (zh) | 一种阿维巴坦中间体的合成方法 | |
CN107778331A (zh) | 一种甲啶铂的提纯方法 | |
CN105085373A (zh) | 一种对阿普斯特产品的纯化方法 | |
JP2015536299A (ja) | ルチン富化抽出物およびそれを製造する方法 | |
CN103172690A (zh) | 醋酸阿比特龙及其中间体的制备方法 | |
CN105348262B (zh) | 一种制备达比加群酯的改进方法 | |
CN103254265B (zh) | 醋酸阿比特龙三氟乙酸盐及其制备方法和应用 | |
CN113185485B (zh) | 一种二氢槲皮素的半合成方法 | |
CN105111188B (zh) | 一种埃索美拉唑镁三水合物晶型的制备方法 | |
CN103601777A (zh) | 一种卡培他滨的制备方法 | |
DE2425983B2 (de) | Sulfonsaeuresalze von acylcholinen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzung | |
CN106146560A (zh) | 一种高纯度磷酸特地唑胺的精制方法 | |
DE69500846T2 (de) | Verfahren zur rückgewinnung von natamycin | |
CN106749226A (zh) | 一种avatrombopag马来酸盐晶型C的制备方法 | |
CN104513156A (zh) | 一种粗均苯三甲酸提纯的方法 | |
CN106187921A (zh) | 一种格列吡嗪结晶的制备方法 | |
CN103554136B (zh) | 一种盐酸头孢甲肟干粉的制备方法 | |
CN106243128B (zh) | 一种头孢妥仑匹酯的精制方法 | |
CN116410161A (zh) | 一种精制呋塞米的方法 | |
CN103755685B (zh) | 一种埃索美拉唑钠的纯化精制方法 | |
CN104163769A (zh) | 一种氯化丙酰左卡尼汀的制备方法 | |
CN113956198A (zh) | 罗沙司他的杂质、其制备方法及其应用 | |
CN105949184A (zh) | 一种盐酸阿罗洛尔的精制方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20221129 Address after: 276006 No. 209 Hongqi Road, Shandong, Linyi Patentee after: LUNNAN BETTER PHARMACEUTICAL Co.,Ltd. Address before: 276005 No. 209 Hongqi Road, Shandong, Linyi Patentee before: LUNAN PHARMACEUTICAL Group Corp. |
|
TR01 | Transfer of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A Method for Purification of Methidine Platinum Effective date of registration: 20230117 Granted publication date: 20200630 Pledgee: Industrial and Commercial Bank of China Limited Linyi Shizhong Sub-branch Pledgor: LUNNAN BETTER PHARMACEUTICAL Co.,Ltd. Registration number: Y2023980031096 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |